- Home
- QURE vs DAN Comparison
QURE vs DAN Comparison
Compare QURE & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | DAN |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.8B |
| IPO Year | 2013 | 2003 |
Fundamental Metrics
Financial Performance| Metric | QURE | DAN |
|---|---|---|
| Price | $43.04 | $30.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $45.00 | $40.60 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | 29.67 | ★ 264.10 |
| EPS | N/A | ★ 9.93 |
| Revenue | $13,107,000.00 | ★ $7,500,000,000.00 |
| Revenue This Year | $126.12 | $1.89 |
| Revenue Next Year | $200.43 | $4.59 |
| P/E Ratio | ★ N/A | $3.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $17.74 |
| 52 Week High | $71.50 | $39.56 |
Technical Indicators
Market Signals| Indicator | QURE | DAN |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 50.60 |
| Support Level | $39.50 | $28.68 |
| Resistance Level | $51.09 | $31.99 |
| Average True Range (ATR) | 2.05 | 0.78 |
| MACD | -0.66 | -0.09 |
| Stochastic Oscillator | 21.68 | 38.27 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About DAN Dana Incorporated
Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.